Spontaneous activity of the mitochondrial apoptosis pathway drives chromosomal defects, the appearance of micronuclei and cancer metastasis through the Caspase-Activated DNAse.


Journal

Cell death & disease
ISSN: 2041-4889
Titre abrégé: Cell Death Dis
Pays: England
ID NLM: 101524092

Informations de publication

Date de publication:
07 04 2022
Historique:
received: 04 11 2021
accepted: 25 03 2022
revised: 16 03 2022
entrez: 8 4 2022
pubmed: 9 4 2022
medline: 12 4 2022
Statut: epublish

Résumé

Micronuclei are DNA-containing structures separate from the nucleus found in cancer cells. Micronuclei are recognized by the immune sensor axis cGAS/STING, driving cancer metastasis. The mitochondrial apoptosis apparatus can be experimentally triggered to a non-apoptotic level, and this can drive the appearance of micronuclei through the Caspase-activated DNAse (CAD). We tested whether spontaneously appearing micronuclei in cancer cells are linked to sub-lethal apoptotic signals. Inhibition of mitochondrial apoptosis or of CAD reduced the number of micronuclei in tumor cell lines as well as the number of chromosomal misalignments in tumor cells and intestinal organoids. Blockade of mitochondrial apoptosis or deletion of CAD reduced, while experimental activation CAD, STING-dependently, enhanced aggressive growth of tumor cells in vitro. Deletion of CAD from human cancer cells reduced metastasis in xenograft models. CAD-deficient cells displayed a substantially altered gene-expression profile, and a CAD-associated gene expression 'signature' strongly predicted survival in cancer patients. Thus, low-level activity in the mitochondrial apoptosis apparatus operates through CAD-dependent gene-induction and STING-activation and has substantial impact on metastasis in cancer.

Identifiants

pubmed: 35393399
doi: 10.1038/s41419-022-04768-y
pii: 10.1038/s41419-022-04768-y
pmc: PMC8990075
doi:

Substances chimiques

Apoptosis Regulatory Proteins 0
DNA 9007-49-2
Deoxyribonucleases EC 3.1.-
caspase-activated deoxyribonuclease EC 3.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

315

Informations de copyright

© 2022. The Author(s).

Références

Cell Rep. 2020 Jun 9;31(10):107731
pubmed: 32521256
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Oncotarget. 2016 Aug 2;7(31):49322-49333
pubmed: 27384994
Cell Death Dis. 2020 Jun 11;11(6):448
pubmed: 32528057
FEBS J. 2017 Apr;284(8):1160-1170
pubmed: 27865056
Nat Methods. 2009 Dec;6(12):917-22
pubmed: 19915560
Int J Mol Sci. 2021 Jun 07;22(11):
pubmed: 34200309
Nature. 1996 Nov 21;384(6606):273-6
pubmed: 8918879
Cell Res. 2017 Jun;27(6):764-783
pubmed: 28337983
Mol Cell. 2013 Apr 25;50(2):273-80
pubmed: 23499004
EMBO J. 2018 Sep 3;37(17):
pubmed: 30049712
J Cell Biol. 1988 Mar;106(3):761-71
pubmed: 2450098
Cell. 2015 May 21;161(5):1202-1214
pubmed: 26000488
J Biol Chem. 2014 Nov 7;289(45):31617-23
pubmed: 25248749
Science. 2018 Feb 23;359(6378):
pubmed: 29472455
Dev Cell. 2019 May 6;49(3):317-324
pubmed: 31063751
PLoS One. 2016 Jun 03;11(6):e0156839
pubmed: 27258544
Nat Immunol. 2003 Feb;4(2):138-44
pubmed: 12524536
Cell. 2014 Dec 18;159(7):1549-62
pubmed: 25525874
Mol Cell. 2019 Feb 7;73(3):413-428.e7
pubmed: 30598363
Mol Cell. 2015 Mar 5;57(5):860-872
pubmed: 25702873
PLoS One. 2013 Dec 18;8(12):e82241
pubmed: 24367507
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Mol Cell. 2010 Feb 12;37(3):299-310
pubmed: 20159550
Nat Cell Biol. 2017 Oct;19(10):1260-1273
pubmed: 28892081
Cell Death Dis. 2020 Feb 13;11(2):124
pubmed: 32054850
Nucleic Acids Res. 2019 Jul 2;47(W1):W556-W560
pubmed: 31114875
EMBO J. 2019 Jun 3;38(11):
pubmed: 30979778
Nat Immunol. 2017 Apr 18;18(5):488-498
pubmed: 28418387
Nature. 2018 Jan 25;553(7689):467-472
pubmed: 29342134
Sci Rep. 2018 Jun 15;8(1):9227
pubmed: 29907753
Nature. 2017 Aug 24;548(7668):461-465
pubmed: 28738408
Nature. 2019 Feb;566(7743):249-253
pubmed: 30700914
Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4230-5
pubmed: 20160104
Nature. 2017 Aug 24;548(7668):466-470
pubmed: 28759889
Cancer Res. 2015 Jan 15;75(2):344-55
pubmed: 25421577
Cell. 2014 Dec 18;159(7):1563-77
pubmed: 25525875
Breast Cancer Res Treat. 2010 Oct;123(3):725-31
pubmed: 20020197
Cancer Med. 2019 Sep;8(12):5574-5576
pubmed: 31397113
Genome Biol. 2010;11(3):R25
pubmed: 20196867
Cell Death Dis. 2015 Mar 05;6:e1675
pubmed: 25741600
Genome Biol. 2010;11(10):R106
pubmed: 20979621
Sci Rep. 2016 May 09;6:25533
pubmed: 27156886
Mol Biol Cell. 2012 Feb;23(4):567-76
pubmed: 22171325
Curr Opin Cell Biol. 2021 Jun;70:91-99
pubmed: 33610905
Cell. 2011 Apr 1;145(1):92-103
pubmed: 21458669
Nature. 1998 Jan 1;391(6662):43-50
pubmed: 9422506
EMBO J. 2020 Jul 15;39(14):e104036
pubmed: 32484965
Nature. 2018 Aug;560(7717):238-242
pubmed: 30046113
Cell Rep. 2016 Apr 5;15(1):210-218
pubmed: 27052166
Cell. 1997 Apr 18;89(2):175-84
pubmed: 9108473

Auteurs

Aladin Haimovici (A)

Institute of Medical Microbiology and Hygiene, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany. aladin.haimovici@uniklinik-freiburg.de.

Christoph Höfer (C)

Institute of Medical Microbiology and Hygiene, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Mohamed Tarek Badr (MT)

Institute of Medical Microbiology and Hygiene, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Elham Bavafaye Haghighi (E)

Institute of Medical Bioinformatics and Systems Medicine, Medical Center -, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Tarek Amer (T)

Institute of Medical Microbiology and Hygiene, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Melanie Boerries (M)

Institute of Medical Bioinformatics and Systems Medicine, Medical Center -, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
German Cancer Consortium DKTK Partner Site Freiburg, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Peter Bronsert (P)

Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Institute for Surgical Pathology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Core Facility for Histopathology and Digital Pathology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Ievgen Glavynskyi (I)

Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Institute for Surgical Pathology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Core Facility for Histopathology and Digital Pathology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Deborah Fanfone (D)

Cancer Research Center of Lyon (CRCL) INSERM 1052, CNRS 5286, Lyon, France.
Cancer Cell Death Laboratory, part of LabEx DEVweCAN, Université de Lyon, Lyon, France.

Gabriel Ichim (G)

Cancer Research Center of Lyon (CRCL) INSERM 1052, CNRS 5286, Lyon, France.
Cancer Cell Death Laboratory, part of LabEx DEVweCAN, Université de Lyon, Lyon, France.

Nico Thilmany (N)

Institute of Medical Microbiology and Hygiene, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Arnim Weber (A)

Institute of Medical Microbiology and Hygiene, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Tilman Brummer (T)

Comprehensive Cancer Center Freiburg, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
German Cancer Consortium DKTK Partner Site Freiburg, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Institute of Molecular Medicine and Cell Research, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
BIOSS Centre for Biological Signalling Studies, University of Freiburg, Freiburg, Germany.

Corinna Spohr (C)

Institute of Molecular Medicine and Cell Research, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Spemann Graduate School for Biology and Medicine, University of Freiburg, Freiburg, Germany.
Faculty of Biology, University of Freiburg, Freiburg, Germany.

Rupert Öllinger (R)

Institute of Molecular Oncology and Functional Genomics, Department of Medicine II and TranslaTUM Cancer Center; TUM School of Medicine, Technical University of Munich, Munich, Germany.

Klaus-Peter Janssen (KP)

School of Medicine, Dept. of Surgery, Technical University of Munich, 81675, Munich, Germany.

Roland Rad (R)

Institute of Molecular Oncology and Functional Genomics, Department of Medicine II and TranslaTUM Cancer Center; TUM School of Medicine, Technical University of Munich, Munich, Germany.

Georg Häcker (G)

Institute of Medical Microbiology and Hygiene, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
BIOSS Centre for Biological Signalling Studies, University of Freiburg, Freiburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH